Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials  W. Moussaoui,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections  A.K.
Matrix-assisted laser-desorption/ionization BIOTYPER: experience in the routine of a University hospital  E. Bessède, M. Angla-gre, Y. Delagarde, S. Sep.
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification  A. Bizzini, G. Greub 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species 
R. Cantón  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review  M. Drancourt 
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: revolutionizing clinical laboratory diagnosis of mould infections  M. Gautier,
Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight.
Rapid method for direct identification of bacteria in urine and blood culture samples by matrix-assisted laser desorption ionization time-of-flight mass.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Use of mass spectrometry to identify clinical Fusarium isolates
Rapid detection of enterobacteriaceae producing extended spectrum beta-lactamases directly from positive blood cultures by matrix-assisted laser desorption.
Results from a mathematical model for human monocytic ehrlichiosis
Diagnosis of Aerococcus urinae infections: Importance of matrix-assisted laser desorption ionization time-of-flight mass spectrometry and broad-range.
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
A novel method for the rapid and prospective identification of Beijing Mycobacterium tuberculosis strains by high-resolution melting analysis  M. Alonso,
Polymerase-chain reaction/electrospray ionization-mass spectrometry for the detection of bacteria and fungi in bronchoalveolar lavage fluids: a prospective.
F. Bittar, J.-M. Rolain  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
The occurrence of Legionella species other than Legionella pneumophila in clinical and environmental samples in Denmark identified by mip gene sequencing.
Automated categorization of methicillin-resistant Staphylococcus aureus clinical isolates into different clonal complexes by MALDI-TOF mass spectrometry 
A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole.
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification.
Hepatitis B and C virus-related carcinogenesis
Laboratory diagnosis of Clostridium difficile disease
Impact of rapid microbial identification directly from positive blood cultures using matrix- assisted laser desorption/ionization time-of-flight mass spectrometry.
Establishment of a matrix-assisted laser desorption ionization time-of-flight mass spectrometry database for rapid identification of infectious achlorophyllous.
Blood culture-based diagnosis of bacteraemia: state of the art
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for species identification of Acinetobacter strains isolated.
Advantages and limitations of genomics in prokaryotic taxonomy
Usefulness of matrix-assisted laser desorption ionisation–time-of-flight mass spectrometry for identifying clinical Trichosporon isolates  J.N. de Almeida.
Abstracts cont. Clinical Microbiology and Infection
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
An after-hours clinical liaison blood culture service—is it worth it?
Clinical Microbiology and Infection
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR- based rapid diagnosis of Staphylococcus aureus bacteraemia  O. Clerc,
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and accurate identification of Pseudallescheria/ Scedosporium species 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip  M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,
Identification of Leishmania at the species level with matrix-assisted laser desorption ionization time-of-flight mass spectrometry  C. Cassagne, F. Pratlong,
Impact of antibiotic restrictions: the patient's perspective
Abstracts Clinical Microbiology and Infection
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay  E.A. Idelevich, K. Sparbier,
Presentation transcript:

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials  W. Moussaoui, B. Jaulhac, A.-M. Hoffmann, B. Ludes, M. Kostrzewa, P. Riegel, G. Prévost  Clinical Microbiology and Infection  Volume 16, Issue 11, Pages 1631-1638 (November 2010) DOI: 10.1111/j.1469-0691.2010.03356.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Identification of polymicrobial results displayed within the BioTyper 2.0 graphic view. The mass spectra shows the difference in peaks (presence or absence) and their intensity between the sample spectrum and those of bacteria identified at first proposals. The upper part of the figure within the inner windows shows the unknown spectrum containing perfectly matching peaks (0–200 p.p.m.) in green, imperfectly matching peaks (200–500 p.p.m.) in yellow, and non-matching peaks in red. The lower part (blue) shows the dedicated main spectrum included in the database. Clinical Microbiology and Infection 2010 16, 1631-1638DOI: (10.1111/j.1469-0691.2010.03356.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions